Tata Elxsi Share Price Target 2024-2030 Fundamentals & Quarterly...

Tata Elxsi Share Price Target 2024-2030 Fundamentals & Quarterly Results
July 10, 2024 by Anjali beniwal. Tata Elxsi Share Price Target 2024 2025 2026 2027 2028 2029 2030 Fundamentals & Quarterly Results –TATA ELXSI is in the industrial sector which covers Automobile, Broadcast, Communication Healthcare and Transport sectors. It engages more than 12000 employees who use design thinking and Digital Technology comprising IoT (Internet of things), Cloud, Mobility, Virtual Reality or AI (Artificial intelligence) applications.

• 1 Tata Elxsi Overview
• 2 Tata Elxsi Business Profile
  • 2.1 Embedded Product & Design
  • 2.2 Industrial Design & Visualization
  • 2.3 System Integration & Support
  • 2.4 Revenue Breakdown
  • 2.5 Client Concentration
  • 2.6 Partnership with INVIDI
  • 2.7 Partner with Brain Chip
  • 2.8 Partners with Ateme
  • 2.9 NEURON Autonomous Network Platform
• 3 Tata Elxsi Fundamentals & Quarterly Results
  • 3.1 Tata Elxsi Quarterly Results
  • 3.2 CAGR Report
  • 3.3 Tata Elxsi Shareholding Pattern
• 4 Tata Elxsi Share Price Target 2024-2030 Forecast
  • 4.1 TATA ELXSI Share Price Target 2025
  • 4.2 TATA ELXSI Share Price Target 2026
  • 4.3 TATA ELXSI Share Price Target 2027
  • 4.4 TATA ELXSI Share Price Target 2028
  • 4.5 TATA ELXSI Share Price Target 2029
  • 4.6 TATA ELXSI Share Price Target 2030.
    Partner with Brain Chip
    Brain Chip has come together with Tata Elxsi to establish edge AI. It is using BrainChip’s first-to-market, fully-digital, neuromorphic technology to provide smart, power-saving solutions for its intended markets, to incorporate Akida™ technology into medical digital equipment, and industrial applications.
    Client Concentration
    Revenue concentration from important clients grew from 46.5 percent up to 53.2% in the second quarter of fiscal year 2024, and it stood at 44.5% on the 5 largest customers.
    Revenue Breakdown
    Transportation : 46.2%
    Media & Communications : 38.4%
    Healthcare & medical devices : 15.4%